Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

4.9K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

9.8K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.4K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.3K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.3K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

13.7K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
13.7K
Mechanisms of Membrane-bending01:15

Mechanisms of Membrane-bending

3.1K
The living membranes are flexible due to their fluid mosaic nature; however, their bending into different shapes is an active process regulated by specific lipids and proteins. The membrane bending can be transient as seen in vesicles or stable for a long time as in microvilli. Cells regulate the size, location, and duration of the membrane curvature.
Membrane bending can happen due to intrinsic changes in lipid composition or extrinsic association with different proteins. The proteins involved...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antioxidant Nanozymes: From Rational Design to Biomedical Applications.

Research (Washington, D.C.)·2026
Same author

The feasibility of ovarian tissue cryopreservation in selected females after hematopoietic stem cell transplantation.

Bone marrow transplantation·2026
Same author

Nanoporous-based biomaterials in biomedical applications: from fundamentals and biosensing to drug delivery, wound healing, and tissue engineering.

Nanoscale advances·2026
Same author

Long-term assessment of nutrient-induced eutrophication in Xiamen Bay: Implications for integrated watershed-coast management.

Marine environmental research·2026
Same author

ERK autoinhibition mechanism informs a drug combination strategy.

Protein science : a publication of the Protein Society·2026
Same author

Helicase A determines the transcription program of T<sub>H</sub>17 lineage differentiation and autoimmunity.

Science advances·2026
Same journal

Inhibiting PPM1D Perturbs Mitochondrial Integrity to Stimulate cGAS-STING Signaling and Antitumor Immunity.

Cancer research·2026
Same journal

BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial Sarcoma.

Cancer research·2026
Same journal

Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung Cancer.

Cancer research·2026
Same journal

Opportunities to enhance cancer research through advocate-researcher partnerships.

Cancer research·2026
Same journal

EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.

Cancer research·2026
Same journal

Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones.

Cancer research·2026
See all related articles

Related Experiment Video

Updated: Dec 6, 2025

Mutagenesis and Functional Analysis of Ion Channels Heterologously Expressed in Mammalian Cells
15:28

Mutagenesis and Functional Analysis of Ion Channels Heterologously Expressed in Mammalian Cells

Published on: October 1, 2010

17.8K

PI3K Driver Mutations: A Biophysical Membrane-Centric Perspective.

Mingzhen Zhang1, Hyunbum Jang1, Ruth Nussinov2,3

  • 1Computational Structural Biology Section, Frederick National Laboratory for Cancer Research in the Laboratory of Cancer Immunometabolism, National Cancer Institute, Frederick, Maryland.

Cancer Research
|October 13, 2020
PubMed
Summary
This summary is machine-generated.

Double mutations in PI3Kα, particularly two strong drivers, enhance enzyme activation by modulating membrane interactions and reducing autoinhibition. Understanding these mechanisms is key to overcoming drug resistance.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.8K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.3K

Related Experiment Videos

Last Updated: Dec 6, 2025

Mutagenesis and Functional Analysis of Ion Channels Heterologously Expressed in Mammalian Cells
15:28

Mutagenesis and Functional Analysis of Ion Channels Heterologously Expressed in Mammalian Cells

Published on: October 1, 2010

17.8K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.8K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.3K

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Structural Biology

Background:

  • Ras-activated signaling pathways involve effectors like PI3Kα and Raf, which assemble at specific cellular locations.
  • PI3Kα activation is influenced by membrane composition and lipid signaling, while Raf's assembly occurs away from the membrane.
  • PI3Kα driver mutations, especially double mutations, significantly impact its activation and cellular function.

Purpose of the Study:

  • To elucidate the mechanisms of PI3Kα activation driven by single and double mutations.
  • To investigate the prevalence and functional consequences of PI3Kα double mutations.
  • To compare PI3Kα activation mechanisms with those of Raf and explore strategies to overcome drug resistance.

Main Methods:

  • Structural analysis of PI3Kα mutations.
  • Biophysical characterization of enzyme kinetics and substrate binding.
  • Comparative analysis of PI3Kα and Raf activation pathways.

Main Results:

  • Double PI3Kα mutations, combining effects on membrane interaction (Km) and catalytic efficiency (Ka), lead to stronger activation than single mutations.
  • Specific double mutations, like H1047R combined with E542K/E545K, effectively release autoinhibition by the nSH2 domain.
  • PI3Kα with double mutations exhibits enhanced sensitivity to inhibitors, suggesting potential therapeutic strategies.

Conclusions:

  • The study provides a structural and biophysical perspective on PI3Kα activation by driver mutations.
  • Understanding the interplay of different mutation types is crucial for comprehending PI3Kα dysregulation.
  • Targeting cell-specific pathways and considering resistance mechanisms are vital for effective therapeutic interventions.